nivolumab
Pronunciation: nye-VOL-ue-mab
Other Name(s): Opdivo®
Appearance: solution mixed into larger bags of fluids
Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Drug Monograph
Oct 2024
Eligibility Forms
Nivolumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) Nivolumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, which is Platinum Resistant or Refractory Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) Nivolumab - Relapsed Classical Hodgkin Lymphoma (cHL) Post-Autologous Stem Cell Transplant (ASCT) or ASCT Ineligible Nivolumab - Advanced or Metastatic Non-Small Cell Lung Cancer Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma Nivolumab plus Ipilimumab - In Combo with Platinum Doublet Chemo for First Line Metastatic or Recurrent NSCLC Nivolumab - First-line Treatment of Advanced Gastric Esophageal and Esophagogastric Junction Adenocarcinoma Nivolumab - Adjuvant Treatment of Completely Resected Esophageal or Esophagogastric Junction Cancer Nivolumab plus Ipilimumab - Metastatic Renal Cell Carcinoma Nivolumab - Advanced or Metastatic Renal Cell Carcinoma and Prior mTOR Inhibitor Nivolumab - Advanced or Metastatic Renal Cell Carcinoma and No Prior mTOR Inhibitor Nivolumab - Adjuvant Treatment of Urothelial Carcinoma Nivolumab - Adjuvant Treatment for Completely Resected Stage III or IV Melanoma Nivolumab - Neoadjuvant Treatment for Non-Small Cell Lung Cancer Nivolumab - In Combination with Cabozantinib for First Line Advanced or Metastatic Renal Cell Carcinoma Nivolumab - Adjuvant Treatment for Completely Resected Stage IIB or IIC MelanomaPatient Info Sheet
Mar 2023
What it is used for
- For treating many types of cancers such as melanoma (skin), lung, renal cell (kidney), colorectal, liver, head and neck, Hodgkin lymphoma, mesothelioma and others
- Nivolumab is an immunotherapy drug. For more information on immunotherapy, click here.